Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

Press releases published on December 21, 2025

Dec. 21, 2025

Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions

GlobeNewswire

Dec. 21, 2025

F5, Inc. (FFIV) Faces Securities Class Action Amid Cybersecurity Incident, Questions About Disclosure Timing and Impact on Company’s Business – Hagens Berman

GlobeNewswire

Dec. 21, 2025

Bronstein, Gewirtz & Grossman LLC Urges Sprouts Farmers Market, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire

Dec. 21, 2025

Bitlock Wallet Confirms Mobile App Launch, Bringing Its All-in-One Crypto Platform to iOS and Android

GlobeNewswire

Dec. 21, 2025

BTDR REMINDER: Kessler Topaz Meltzer & Check, LLP Urges BTDR Investors with Losses to Contact the Firm

GlobeNewswire

Dec. 21, 2025

SNPS COURT REMINDER: Synopsys, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before December 30

GlobeNewswire

Dec. 21, 2025

Rocket Lab Successfully Launches for iQPS, Ends 2025 with 21 Launches and 100% Mission Success

GlobeNewswire

Dec. 21, 2025

Sapu BioScience 强调通过 TGFB2 导向策略增强紫杉类药物治疗效果，进一步夯实 Sapu-001 的科学依据

GlobeNewswire

Dec. 21, 2025

Sapu BioScience 重點介紹以 TGFB2 為導向的策略，旨在提升紫杉烷類療法，鞏固 Sapu-001 的理論基礎

GlobeNewswire

Tech Times of New York: Press Releases

December 2025

January 2026

February 2026

Press releases published on December 21, 2025

Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions

F5, Inc. (FFIV) Faces Securities Class Action Amid Cybersecurity Incident, Questions About Disclosure Timing and Impact on Company’s Business – Hagens Berman

Bronstein, Gewirtz & Grossman LLC Urges Sprouts Farmers Market, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bitlock Wallet Confirms Mobile App Launch, Bringing Its All-in-One Crypto Platform to iOS and Android

BTDR REMINDER: Kessler Topaz Meltzer & Check, LLP Urges BTDR Investors with Losses to Contact the Firm

SNPS COURT REMINDER: Synopsys, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before December 30

Rocket Lab Successfully Launches for iQPS, Ends 2025 with 21 Launches and 100% Mission Success

Sapu BioScience 强调通过 TGFB2 导向策略增强紫杉类药物治疗效 果，进一步夯实 Sapu-001 的科学依 据

Sapu BioScience 重點介紹以 TGFB2 為導向的策略，旨在提升紫杉烷類療法，鞏固 Sapu-001 的理論基礎

Sapu BioScience 强调通过 TGFB2 导向策略增强紫杉类药物治疗效果，进一步夯实 Sapu-001 的科学依据